These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10419606)

  • 1. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population.
    Monaghan KG; Feldman GL
    Prenat Diagn; 1999 Jul; 19(7):604-9. PubMed ID: 10419606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is testing for cytomegalovirus and cystic fibrosis indicated in members of a nonwhite pregnant population in whom the fetus has an echogenic bowel?
    Aboujaoude R; Alvarez J; Ganesh V; Apuzzio J
    Am J Perinatol; 2006 Jul; 23(5):319-23. PubMed ID: 16799919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.
    Bosco AF; Norton ME; Lieberman E
    Obstet Gynecol; 1999 Dec; 94(6):1020-3. PubMed ID: 10576193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of fetal echogenic bowel.
    Al-Kouatly HB; Chasen ST; Streltzoff J; Chervenak FA
    Am J Obstet Gynecol; 2001 Nov; 185(5):1035-8. PubMed ID: 11717628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel.
    Berlin BM; Norton ME; Sugarman EA; Tsipis JE; Allitto BA
    Obstet Gynecol; 1999 Jul; 94(1):135-8. PubMed ID: 10389734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island.
    Miller ME; Allen VM; Brock JK
    J Obstet Gynaecol Can; 2018 Jul; 40(7):896-902. PubMed ID: 29503250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.
    Muller F; Simon-Bouy B; Girodon E; Monnier N; Malinge MC; Serre JL;
    Am J Med Genet; 2002 Jun; 110(2):109-15. PubMed ID: 12116247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal echogenic bowel and a dilated loop of bowel associated with cystic fibrosis (CF) mutations delta F508 and 2183AA-->G.
    Rush PW; Vats S; Allitto BA; Qureshi F; Feldman GL
    Prenat Diagn; 1998 Jun; 18(6):638-40. PubMed ID: 9664617
    [No Abstract]   [Full Text] [Related]  

  • 9. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
    ; Prabhu M; Kuller JA; Biggio JR
    Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations.
    Hodge SE; Lebo RV; Yesley AR; Cheney SM; Angle H; Milunsky J
    Am J Med Genet; 1999 Feb; 82(4):329-35. PubMed ID: 10051167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of fetal echogenic bowel.
    Slotnick RN; Abuhamad AZ
    Lancet; 1996 Jan; 347(8994):85-7. PubMed ID: 8538346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
    Palomaki GE; FitzSimmons SC; Haddow JE
    Genet Med; 2004; 6(5):405-14. PubMed ID: 15371905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.
    Haque IS; Lazarin GA; Kang HP; Evans EA; Goldberg JD; Wapner RJ
    JAMA; 2016 Aug; 316(7):734-42. PubMed ID: 27533158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperechogenic fetal bowel as a marker of fetal cystic fibrosis].
    Sukupová M; Dhaifalah I; Adamík Z; Havalová J
    Ceska Gynekol; 2015 Jan; 80(1):20-4. PubMed ID: 25723074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.
    Sepulveda W; Leung KY; Robertson ME; Kay E; Mayall ES; Fisk NM
    Obstet Gynecol; 1996 Jan; 87(1):103-6. PubMed ID: 8532242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal echogenic bowel on ultrasound: is there clinical significance?
    Sipes SL; Weiner CP; Wenstrom KD; Williamson RA; Grant SS; Mueller GM
    Fetal Diagn Ther; 1994; 9(1):38-43. PubMed ID: 8142051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Towards an improved antenatal screening for cystic fibrosis].
    Serre JL; Feingold J; Simon-Bouy B; Muller F
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fetal echogenic bowel by ultrasound: what is the clinical significance?].
    Bashiri A; Burstein E; Hershkowitz R; Mazor M
    Harefuah; 2007 Dec; 146(12):964-9, 996-7. PubMed ID: 18254450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of cystic fibrosis in fetuses with dilated bowel.
    Estroff JA; Parad RB; Benacerraf BR
    Radiology; 1992 Jun; 183(3):677-80. PubMed ID: 1584918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cystic fibrosis with prenatally detected echogenic bowel.
    Ferriman EL; Mason G; Ellis L
    Prenat Diagn; 1999 Dec; 19(12):1177. PubMed ID: 10590441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.